- Probiotics may offer sufferers non-drug option for symptom relief -
TOKYO, Nov. 3 /PRNewswire/ -- Last Friday, the 17th Annual Symposium on Intestinal Flora at Yakult World Headquarters Hall in Tokyo gathered physicians, researchers and company associates from 19 countries, including the U.S. This year's theme, "Intestinal Microbiota and Functional Gastrointestinal Disorders" focused on brain-gut interactions and Irritable Bowel Syndrome, which is believed to be the "entry illness" that leads to various digestive diseases.
IBS affects up to 25% of the world population and roughly one in five Americans. It is caused by an inflammatory reaction in the intestines, often triggered by stress, and results in a change to gut microflora. These mechanisms and other new discoveries about the brain-gut relationship were presented to a packed room of more than 500 attendees.
"Probiotics show promise for manipulating gut microflora," predicated Stephen M. Collins of McMaster University, Canada concluding his presentation, 'The Influence of Commensally Bacteria on the Gut-Brain Axis.' Probiotics are appealing for IBS sufferers since they are not drugs, have no side effects and can help maintain intestinal balance.
Other presentations included: "Stress and brain-gut interactions in
IBS," by Shin Fukudo (Tohoku University, Japan); "Intestinal inflammation
and motor function," by Hiroshi Ozaki (University of Tokyo); "Effect of
stress-related peptides on colonic motility," by Shigeru Yamato
(International Medical Center of Japan, Konodai Hospital); "Probiotics and
IBS," by Eamonn M. Quigley (Cork University, Ireland); "Stress and
intestinal microbiota," by Michael T. Bailey (Ohio State University); and
"IBS: medicine and probiotics," by Mitsuhisa Kawai (Yakult Central
Institute for Microbiologic
|SOURCE Yakult U.S.A. Inc.|
Copyright©2008 PR Newswire.
All rights reserved